RE:RE:RE:RE:RE:RE:Monsanto "Big Data"
I'm not sure takeover talk is premature at this point. The company has restructured. There has been a lot of turnover in shares held meaning many holders, including the largest shareholder, are now in the money and may be tempted to take a deal. Yes there is a poison pill in place but ultimately the decision to sell rests with the board, not management. However if management presents a growth plan that justifies their view that the stock is severely undervalued then perhaps the board will wait to see if results are achieved. Still, one has to think that an offer north of ~$2.00 would see a deal get done. It would be tough to turn that down.
My personal opinion is that while I think there is a strong possibility, even today, for a takeover I'm hopeful it doesnt happen as I think shareholders would leave significant money on the table. But with consolidation in the industry likely to accelerate, as evidenced by Monsanto and others, we may wake up one morning and see a news release that Agjunction has chosen to sell.
I really hope that management, as part of their upcoming investor marketing tour, decide to release some form of 5-year plan which quantifies the potential of the business and sets milestones/targets. They have done a decent job providing qualitative comments about why the company should experience growth, but without quantifying the opportunity investors have little to go by and very few institutions are going to take the time to learn about a micro-cap company on the TSX.